Showing results (141-150 of 196) with videos related to

Sort By:
Pageof 20
Zentralblatt Fur Chirurgie|December 19, 2008
[Filling of metaphyseal defects with nanocrystalline hydroxyapatite (Ostim) for fractures of the radius]F-X Huber, J Hillmeier, H-J Kock, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 9, 2020
Inhibition of cardiac potassium currents by oxidation-activated protein kinase A contributes to early afterdepolarizations in the heartM Trum, M M T Islam, S Lebek, et al.
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|January 28, 2016
Prediction of immediate and long-term benefit after kyphoplasty of painful osteoporotic vertebral fractures by preoperative MRII A Grafe, G Nöldge, C Weiss, et al.
Osteoarthritis and Cartilage Open|March 18, 2024
Implementing an osteoarthritis management program to deliver guideline-driven care for knee and hip osteoarthritis in a U.S. academic health systemKathryn A Miller, Linda M Baier Manwell, Christie M Bartels, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 26, 2007
First confirmed autochthonous case of human Babesia microti infection in EuropeA Hildebrandt, K-P Hunfeld, M Baier, et al.
The Journal of Clinical Endocrinology and Metabolism|February 13, 2014
Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter studyT Diana, R S Brown, A Bossowski, et al.
Anais Da Academia Brasileira De Ciencias|November 25, 2020
Development of nanoparticles coated with cassava bagasse pectin (Manihot esculenta Crantz) containing β-carotene for mucoadhesive applicationsBianca Coelho, LetÍcia Mazzarino, HeloÍsa S Pitz, et al.
Journal of Immunological Methods|October 18, 2005
Generation and characterisation of monoclonal antibodies to Rainbow trout (Oncorhynchus mykiss) prion proteinB C Maddison, S Patel, R F James, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemiaA F List, C Spier, J Greer, et al.
Pageof 20